Prostate cancer (Pea) is a major cause for morbidity and mortality in aging men. Androgen receptor (AR) expression and response to androgens (pathways) in prostate epithelial (PE) cells are key determinants of PCa. Interestingly, there exists a strong androgen regulated immune/ inflammatory signature within the PE cells. In the normal PE, androgens promote anti-tumor acute inflammation and suppress pro-tumor chronic inflammation pathway. Since inflammation of the prostate is the earliest known precursor of prostate cancer therefore altered expression or genetic differences in the genes involved in mediating androgen dependent inflammatory/ immune response can be a risk factor for the development of prostate cancer. Can these genetic differences within the androgen regulated immune/ inflammatory pathways also account for the higher incidence of PCa in African American men? In order to address this question we propose that """"""""""""""""The observed racial disparity in prostate cancer incidence is due to genetic differences in the expression/ polymorphism within a group of androgen regulated immune/ inflammatory pathway and that the genes within this pathway can be used as effective prognostic markers of prostate cancer in racially diverse populations"""""""". The results will demonstrate that the perturbations in the androgen dependent inflammatory/ immune response pathway can lead to a locally (prostate) compromised immune response that pre-disposes to PCa or following acquisition of androgen independence, promotes the development of aggressive PCa in African Americans. The project will analyze expression of the following gene set: Acute: IFNG, IFNA, MX1, OAS1, PKR, CXCL10 and Chronic : IL6, JUNB, CEBPD, GP130. In addition analysis of specific SNPs in IFNG, IL6, OAS1, MX1 and PKR is also proposed. The samples will consist of normal prostate and prostate cancer tissue obtained from African-American and Caucasian men. The highest incidence rates for Pea and mortality in the world are among African-American men. The alterations in the immune/ inflammatory pathway due to de-regulated expression or genetic polymorphism can provide the molecular basis of higher prostate cancer incidence in African-American men. The proposed studies will address these molecular mechanisms. An understanding of these risk factors for cancer thus has practical importance for prognosis, public health efforts, genetic and nutritional education and developing better treatment regimens.
| Elliott, Bethtrice; Zackery, DeAdra L; Eaton, Vanessa A et al. (2018) Ethnic differences in TGF?-signaling pathway may contribute to prostate cancer health disparity. Carcinogenesis 39:546-555 |
| Kimbrough-Allah, Mawiyah N; Millena, Ana C; Khan, Shafiq A (2018) Differential role of PTEN in transforming growth factor ? (TGF-?) effects on proliferation and migration in prostate cancer cells. Prostate 78:377-389 |
| Scarlett, Kisha A; White, El-Shaddai Z; Coke, Christopher J et al. (2018) Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits G?13/RhoA-mediated Migration. Mol Cancer Res 16:728-739 |
| Caggia, Silvia; Chunduri, HimaBindu; Millena, Ana C et al. (2018) Novel role of Gi?2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells. J Cell Physiol 234:802-815 |
| Hawsawi, Ohuod; Henderson, Veronica; Burton, Liza J et al. (2018) High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer. Biochem Biophys Res Commun 504:196-202 |
| Burton, Liza J; Henderson, Veronica; Liburd, Latiffa et al. (2017) Snail transcription factor NLS and importin ?1 regulate the subcellular localization of Cathepsin L and Cux1. Biochem Biophys Res Commun 491:59-64 |
| Morton, Derrick J; Patel, Divya; Joshi, Jugal et al. (2017) ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation. Oncotarget 8:2536-2549 |
| Barrett, Cachétne S X; Millena, Ana C; Khan, Shafiq A (2017) TGF-? Effects on Prostate Cancer Cell Migration and Invasion Require FosB. Prostate 77:72-81 |
| Joshi, Jugal Bharat; Patel, Divya; Morton, Derrick J et al. (2017) Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol 11:337-357 |
| Komaragiri, Shravan Kumar; Bostanthirige, Dhanushka H; Morton, Derrick J et al. (2016) ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells. Biochem Biophys Res Commun 478:60-66 |
Showing the most recent 10 out of 56 publications
